Indivior Pharmaceuticals Inc (INDV)
$35.83+1.07%Close
BUYRECOVERY · day 17
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $4.5B
- Beta
- 1.11
- P/E (TTM)
- 12.64
- Short % float
- 9.29%
- Days to cover
- 5.3
- SI change
- -6.8%
- 1W
- +0.34%
- 1M
- +3.82%
- vs SPY 1W
- -0.82%
- vs SPY 1M
- +0.83%
Industry peers
FMP comparable companies · ranked by market cap
- CRNXBUYCrinetics Pharmaceuticals, Inc.$9.0BBULLQ 26$84.95+0.00%
- PRAXSELLPraxis Precision Medicines, Inc.$7.9BCRISISQ 11$283.56-1.40%
- HNGEBUYHinge Health, Inc.$7.6BBULLQ 74$98.35+5.00%
- LNTHSELLLantheus Holdings, Inc.$6.5BBEARQ 31$100.19+0.03%
- AMRXBUYAmneal Pharmaceuticals, Inc.$6.5BBULLQ 15$20.35+1.32%
- OPCHBUYOption Care Health, Inc.$3.5BBULLQ 7$23.37+0.06%
- ACADSELLAcadia Pharmaceuticals Inc.$3.4BCRISISQ 18$20.11+1.02%
- VKTXSELLViking Therapeutics, Inc.$3.4BCRISISQ 22$29.28+2.81%
- SUPNBUYSupernus Pharmaceuticals, Inc.$2.5BRECOVERYQ 26$42.76+1.26%
- ADMABUYADMA Biologics, Inc.$2.3BRECOVERYQ 9$10.11+0.29%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on INDV?
- LOPJLB’s latest quantitative signal on Indivior Pharmaceuticals Inc (INDV) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is INDV in?
- Indivior Pharmaceuticals Inc (INDV) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Indivior Pharmaceuticals Inc (INDV) do?
- Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the Unite…